KATE YOUNG: Open Payments
NPI 1033767504 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 15 payments from 10 companies in 2025. Trend: 2023 $162 · 2024 $491 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $71 |
| Lilly USA, LLC | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $34 |
| Exact Sciences Corporation | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: MOUNJARO, Ozempic, FARXIGA, Rybelsus, INSPIRE, Cologuard Collection Kit, REXULTI, VRAYLAR.
Industry payments across TX — which companies pay providers there.
